Gregory Plautz, M.D.
| Appointed: |
2002 |
| Gender: |
Male |
| Languages: |
English |
Pediatric Hematology and Oncology
Immunology
Biographical Sketch
Gregory Plautz, MD, is Chair of the Department of Pediatric Hemagology-Oncology at Cleveland Clinic’s main campus. He accepted that appointment in 2007. Since 2002, he has been an Associate Professor of Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He also was an Associate Professor and Chief in the Section of Pediatric Hematology/Oncology at Yale University School of Medicine. He began teaching pediatrics at the University of Michigan, a position he held for four years.
His clinical interests include pediatric hematology/oncology, cancer research and immunology.
Dr. Plautz completed his medical degree at Indiana University School of Medicine. He was an intern and resident in pediatrics at Johns Hopkins Hospital. He completed a fellowship in pediatric hematology-oncology at the University of Michigan Medical Center. He holds a Federal DEA license and is licensed to practice medicine in Ohio.
Dr. Plautz is the author or co-author of numerous original peer-reviewed manuscripts, reviews and book chapters. He is a member of the American Association of Immunologists, American Society of Hematology, American Association for Cancer Research and International Society for Biological Therapy of Cancer.
Education & Fellowships
| Medical School: | Indiana University School of Medicine, Indianapolis, IN |
|
| Internship: | Johns Hopkins Hospital, Pediatrics, Baltimore, MD |
| Residency: | Johns Hopkins Hospital, Pediatrics, Baltimore, MD |
| Fellowship: | University of Michigan Health System, Pediatric Hematology-Oncology, Ann Arbor, MI |
| Other Education: | (Undergraduate) Washington University, St. Louis, MO |
Certifications
Pediatric Hematology-Oncology
Specialty Interests
Cancer research, immunology, pediatric hematology/oncology, childhood cancer, general clinical hematology and oncology, Hodgkin lymphoma, pediatric hematology, pediatric oncology.
Awards & Honors
Current Grant Funding
Dendritic cell-brain tumor cell fusion vaccine; Principal Investigator, Gregory E. Plautz, MD; NIH-NCI, RO1 CA120893; 4/07 to 3/12
Aims: 1) To derive BTSC cell lines and autologous DC-tumor fusion cells from patients with GBM, oligoastrocytoma or medulloblastoma. 2) To determine whether active or adoptive immunotherapy induces therapeutic and/or pathologic effects in murine models. 3) To sensitize T cells from brain tumor patients in vitro with DC-BTSC fusion cells and analyze their reactivity against autologous tumor as an approach to adoptive transfer.
Previous Grant Funding
Dendritic cell-GBM fusion cell vaccines; Principal Investigator, Gregory E. Plautz, MD; Brain Tumor Society, 11/1/2006 to 4/1/07
T-cell immunotherapy of pediatric brain tumors; Principal Investigator, Gregory Plautz, MD; 1 RO1 CA91891; 6/1/02 to 5/31/06
Professional Memberships
- American Society of Hematology
- American Association of Immunologists
- American Association for Cancer Research
- International Society for Biological Therapy of Cancer
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Plautz has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
